Microba Life Sciences Ltd
ASX:MAP
Microba Life Sciences Ltd
Total Equity
Microba Life Sciences Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Microba Life Sciences Ltd
ASX:MAP
|
Total Equity
AU$32.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
Sonic Healthcare Ltd
ASX:SHL
|
Total Equity
AU$8.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Total Equity
AU$693m
|
CAGR 3-Years
26%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Capitol Health Ltd
ASX:CAJ
|
Total Equity
AU$110.9m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
11%
|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Total Equity
AU$171.4m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
H
|
Healius Ltd
ASX:HLS
|
Total Equity
AU$587.9m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-13%
|
|
Microba Life Sciences Ltd
Glance View
Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health. The company is headquartered in Brisbane, Queensland. The company went IPO on 2022-04-05. The firm specializes in the analysis of gut microbiome and promotes development in pathology services, therapeutics and diagnostics based on the microbiome. The firm's flagship product is the Microba Insight, a sampling kit that allows the public to analyze personal gut microbiome. Its discovery platform uses human data and informatic approaches to connect microbial genotype to human phenotype. The company also offers support solutions to researchers.
See Also
What is Microba Life Sciences Ltd's Total Equity?
Total Equity
32.5m
AUD
Based on the financial report for Jun 30, 2025, Microba Life Sciences Ltd's Total Equity amounts to 32.5m AUD.
What is Microba Life Sciences Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
33%
Over the last year, the Total Equity growth was -21%. The average annual Total Equity growth rates for Microba Life Sciences Ltd have been -1% over the past three years , 33% over the past five years .
